Isolasi Senyawa Aktif dari Ekstrak Hipokotil Sarang Semut (Myrmecodia pendens Merr. & Perry) sebagai Penghambat Xantinoksidase
Abstract
Medicinal plant called “sarang semut”, Myrmecodia pendens Merr. & Perry (Rubiaceae), is an epiphyt plant traditionally used in Papua for healing various diseases such as hyperuricemia, rheumatic, and cancer. A chemical compound recognized as xanthinoxidase inhibitor has been isolated from n-buthanol fraction of the plant extract. The isolation was carried out by column chromatography (SiO2, CHCI3-MeOH = 5:1-1:1) and the purification Was conducted using high pressure liquid chromatography (RP, C-18; MeOH-water = 5 : 1). The activity test for Xanthinoxidase inhibitor Was performmed by using modilied Noro method. The pure compound showed xanthinoxidase inhibitor activity of IC50 at 79,77%.
References
2. Fajri FA, Rachman AA. Menyibak misteri rumah Sang Koloni. Natural. 2006.15:15-7.
3. Rachman AA. Senyawa aktif bersarang di sarang semut. Natural. 2006. 15: 18-20.
4. Huxley CR, J ebb MHP. The tuberous epiphytes of the Rubiaceae 5: A revision of Myrmecodia. Blumea.
1993.37(2):232.
5. Owen PR, Johns T. Xanthine Oxidase inhibitory activity of Northeastern North American plant remedies used for gout. J Ethno Pharm. 1999.64:149-53.
6. Gonzalez AG, Bazzochi, Gupta MP. Xanthine oxidase inhibitory activity of some Panamanian plants from Celastraceae and Laminaceae. J Ethnopharmacology. 1995.46:25-9.
7. Tsutomi N, Masatoshi N, Akira I. Two new poten inhibitors ofxanthine oxidase from leaves of Perilla jifustencens Britten, var. Acuta Kudo. Chem & Pharm. Bull. 1990.38(6):1772-74.
Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.
This licence applies to Author(s) and Public Reader means that the users mays :
- SHARE:
copy and redistribute the article in any medium or format - ADAPT:
remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication) - ALIKE:
If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original. - NO ADDITIONAL RESTRICTIONS:
You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
It does however mean that when you use it you must:
- ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
You may not:
- NONCOMMERCIAL: You may not use the article for commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.